Development of intranasal vaccine for SARS-CoV-2 virus and evaluation of immune response in vivo
- Funded by Academy of Finland
- Total publications:0 publications
Grant number: unknown
Grant search
Key facts
Disease
COVID-19Funder
Academy of FinlandPrincipal Investigator
Seppo Ylä-HerttualaResearch Location
FinlandLead Research Institution
Itä-Suomen yliopistoResearch Priority Alignment
N/A
Research Category
Vaccines research, development and implementation
Research Subcategory
Pre-clinical studies
Special Interest Tags
N/A
Study Type
Unspecified
Clinical Trial Details
N/A
Broad Policy Alignment
Pending
Age Group
Not Applicable
Vulnerable Population
Not applicable
Occupations of Interest
Not applicable